These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
954 related articles for article (PubMed ID: 7439628)
21. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution. Iwamura K Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354 [TBL] [Abstract][Full Text] [Related]
22. Analysis of response to ursodeoxycholic acid for gallstone dissolution. Bateson MC; Hill A; Bouchier IA Digestion; 1980; 20(5):358-64. PubMed ID: 7390061 [TBL] [Abstract][Full Text] [Related]
23. Routine determination of biliary lipid composition with the entero-test. Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414 [TBL] [Abstract][Full Text] [Related]
24. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792 [TBL] [Abstract][Full Text] [Related]
25. The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption. Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F Gastroenterology; 1979 Aug; 77(2):223-30. PubMed ID: 447035 [TBL] [Abstract][Full Text] [Related]
26. Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey. Bazzoli F; Roda A; Fromm H; Sarva RP; Roda E; Barbara L Dig Dis Sci; 1982 May; 27(5):417-24. PubMed ID: 7075428 [TBL] [Abstract][Full Text] [Related]
27. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones. Nowak M; Panveliwalla D; Pertsemlidis D Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868 [No Abstract] [Full Text] [Related]
28. Oral cholelitholysis--cheno versus urso: Japanese experience. Nakayama F Dig Dis Sci; 1980 Feb; 25(2):129-34. PubMed ID: 6986241 [TBL] [Abstract][Full Text] [Related]
29. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid. Fromm H Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267 [No Abstract] [Full Text] [Related]
30. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone. Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972 [TBL] [Abstract][Full Text] [Related]
31. [Correlation of biliary cholesterol, phospholipids and bile acid compositions and the development of cholesterol cholelithiasis in mice]. Yamahara J; Chisaka T; Sawada T; Fujimura H Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):171-80. PubMed ID: 6662416 [TBL] [Abstract][Full Text] [Related]
32. Bile acids in bile during long-term chenodeoxycholic acid treatment. Bremmelgaard A; Pedersen L Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436 [TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction. Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925 [TBL] [Abstract][Full Text] [Related]
34. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones. Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674 [No Abstract] [Full Text] [Related]
35. Early morphologic and enzymatic changes in livers of rats treated with chenodeoxycholic and ursodeoxycholic acids. Shefer S; Zaki FG; Salen G Hepatology; 1983; 3(2):201-8. PubMed ID: 6832710 [TBL] [Abstract][Full Text] [Related]
36. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients. Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey. Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382 [TBL] [Abstract][Full Text] [Related]
39. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids. Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719 [TBL] [Abstract][Full Text] [Related]
40. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid. Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]